Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilhelm G Dirks

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|May 21, 2021
Ethical Challenges Using Human Tumor Cell Lines in Cancer ResearchWilhelm G Dirks
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2004
Authentication of scientific human cell lines: easy-to-use DNA fingerprintingWilhelm G Dirks, Hans G Drexler
Methods in Molecular Biology (Clifton, N.J.)|November 27, 2012
STR DNA typing of human cell lines: detection of intra- and interspecies cross-contaminationWilhelm G Dirks, Hans G Drexler
Methods in Molecular Medicine|November 25, 2003
Authentication of cancer cell lines by DNA fingerprintingWilhelm G Dirks, Hans G Drexler
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2011
Online verification of human cell line identity by STR DNA typingWilhelm G Dirks, Hans G Drexler
International Journal of Cancer|August 1, 2012
Where have all the cell lines gone?Roderick A F MacLeod, Wilhelm G Dirks, Hans G Drexler
International Journal of Cancer|January 4, 2008
One falsehood leads easily to anotherRoderick A F MacLeod, Wilhelm G Dirks, Hans G Drexler
Leukemia Research|June 13, 2003
Tumor necrosis factor receptor-associated factor (TRAF) 4 is a new binding partner for the p70S6 serine/threonine kinaseDiana S Fleckenstein, Wilhelm G Dirks, Hans G Drexler, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2013
Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancersClaudia Maletzki, Fabian Schmidt, Wilhelm G Dirks, et al.
International Journal of Cancer|September 19, 2012
Kaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell lineMichael Stürzl, Dominika Gaus, Wilhelm G Dirks, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|May 21, 2021
Ethical Challenges Using Human Tumor Cell Lines in Cancer ResearchWilhelm G Dirks
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2004
Authentication of scientific human cell lines: easy-to-use DNA fingerprintingWilhelm G Dirks, Hans G Drexler
Methods in Molecular Biology (Clifton, N.J.)|November 27, 2012
STR DNA typing of human cell lines: detection of intra- and interspecies cross-contaminationWilhelm G Dirks, Hans G Drexler
Methods in Molecular Medicine|November 25, 2003
Authentication of cancer cell lines by DNA fingerprintingWilhelm G Dirks, Hans G Drexler
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2011
Online verification of human cell line identity by STR DNA typingWilhelm G Dirks, Hans G Drexler
International Journal of Cancer|August 1, 2012
Where have all the cell lines gone?Roderick A F MacLeod, Wilhelm G Dirks, Hans G Drexler
International Journal of Cancer|January 4, 2008
One falsehood leads easily to anotherRoderick A F MacLeod, Wilhelm G Dirks, Hans G Drexler
Leukemia Research|June 13, 2003
Tumor necrosis factor receptor-associated factor (TRAF) 4 is a new binding partner for the p70S6 serine/threonine kinaseDiana S Fleckenstein, Wilhelm G Dirks, Hans G Drexler, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2013
Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancersClaudia Maletzki, Fabian Schmidt, Wilhelm G Dirks, et al.
International Journal of Cancer|September 19, 2012
Kaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell lineMichael Stürzl, Dominika Gaus, Wilhelm G Dirks, et al.
Pageof 6